Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haoyan Li

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Scientific Reports|May 14, 2021
Thymic transcriptome analysis after Newcastle disease virus inoculation in chickens and the influence of host small RNAs on NDV replicationLiangxing Guo, Zhaokun Mu, Furong Nie, et al.
Journal of Medicinal Chemistry|November 21, 2017
Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer TreatmentJingjing Xie, Xiaojia Si, Shoulai Gu, et al.
Science Immunology|April 28, 2023
Alternative splicing of <i>GSDMB</i> modulates killer lymphocyte-triggered pyroptosisQing Kong, Shiyu Xia, Xingxin Pan, et al.
Science Translational Medicine|May 10, 2023
Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficienciesWei Shi, Yin Wang, Yuehui Zhao, et al.
Science China. Life Sciences|July 26, 2024
Single-cell omics: experimental workflow, data analyses and applicationsFengying Sun, Haoyan Li, Dongqing Sun, et al.
Cancer Research|June 30, 2022
CHD1 Promotes Sensitivity to Aurora Kinase Inhibitors by Suppressing Interaction of AURKA with Its Coactivator TPX2Haoyan Li, Yin Wang, Kevin Lin, et al.
Nature Cancer|May 13, 2025
CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumorsFeiyu Chen, Haoyan Li, Yin Wang, et al.
Cancer Discovery|May 10, 2020
Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate CancerDi Zhao, Li Cai, Xin Lu, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Scientific Reports|May 14, 2021
Thymic transcriptome analysis after Newcastle disease virus inoculation in chickens and the influence of host small RNAs on NDV replicationLiangxing Guo, Zhaokun Mu, Furong Nie, et al.
Journal of Medicinal Chemistry|November 21, 2017
Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer TreatmentJingjing Xie, Xiaojia Si, Shoulai Gu, et al.
Science Immunology|April 28, 2023
Alternative splicing of <i>GSDMB</i> modulates killer lymphocyte-triggered pyroptosisQing Kong, Shiyu Xia, Xingxin Pan, et al.
Science Translational Medicine|May 10, 2023
Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficienciesWei Shi, Yin Wang, Yuehui Zhao, et al.
Science China. Life Sciences|July 26, 2024
Single-cell omics: experimental workflow, data analyses and applicationsFengying Sun, Haoyan Li, Dongqing Sun, et al.
Cancer Research|June 30, 2022
CHD1 Promotes Sensitivity to Aurora Kinase Inhibitors by Suppressing Interaction of AURKA with Its Coactivator TPX2Haoyan Li, Yin Wang, Kevin Lin, et al.
Nature Cancer|May 13, 2025
CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumorsFeiyu Chen, Haoyan Li, Yin Wang, et al.
Cancer Discovery|May 10, 2020
Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate CancerDi Zhao, Li Cai, Xin Lu, et al.
Pageof 5